TransEnterix (NYSE:TRXC) said today it filed an FDA 510(k) submission looking to expand the indications for its Senhance robotic surgical platform to include laparoscopic inguinal hernia and laparoscopic cholecystectomy surgeries. The Research Triangle Park, N.C.-based company said that with the additional indications, its Senhance system would be cleared for use in the most common abdominal surgeries in […]
TransEnterix
TransEnterix deals SurgiBot assets for $29m to China’s Great Belief International
TransEnterix (NYSE:TRXC) said today that it agreed to deal its SurgiBot assets to Chinese medtech investment firm Great Belief International for $29 million. The agreement calls for Research Triangle Park, N.C.-based TransEnterix to retain the distribution rights to SurgiBot, which it shelved last year, outside of the U.S. Get the full story on our sister site, The […]
TransEnterix opens the doors to a competitive US surgical robotics market
The surgical robotics market in the US has finally become competitive. In October, the FDA granted clearance to only the second robotic surgical system to date – TransEnterix‘s (NYSE:TRXC) Senhance laparoscopic platform. The clearance was a huge milestone for the Morrisville, N.C.-based company and was quickly followed by yet another – almost exactly a month after […]
TransEnterix logs first U.S. sale, meets Q3 earnings expectations
TransEnterix (NYSE:TRXC) shares jumped today after the medical device company said it sold its first Senhance robot-assisted surgery platform in the U.S., exactly a month after winning FDA clearance. The sale, to Florida Hospital in Orlando, follows another sale in Taiwan made during the third quarter, president & CEO Todd Pope said during a conference call […]
TransEnterix CEO Pope, riding high on FDA nod, eyes the laparoscopic surgery market
Share prices for TransEnterix (NYSE:TRXC) have more than doubled since the robot-assisted surgery company won an important clearance from the FDA last week and CEO Todd Pope is optimistic about his companies chances against the undisputed market leader, Intuitive Surgical (NSDQ:ISRG). Morrisville, N.C.-based TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clearance bid last month after […]
TransEnterix wins FDA nod for Senhance robot-assisted surgery platform
TransEnterix (NYSE:TRXC) said last week that it won 510(k) clearance from the FDA for its Senhance robot-assisted surgery platform. TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clerarance bid last month after applying in April. Get the full story from our sister site, The Robot Report.
TransEnterix escapes shareholders lawsuit
TransEnterix (NYSE:TRXC) last week won the dismissal of a shareholders lawsuit brought over the collapse of its SurgiBot program, with a federal judge ruling that the company and its management and investors didn’t mislead shareholders about the robot-assisted surgery platform’s prospects with the FDA. The case dates back to the spring of 2016, when Research Triangle Park, […]
TransEnterix responds to FDA more info request
Robotics medical company TransEnterix filed its response to the Food and Drug Administration’s additional information request on its Senhance Surgical Robotic System 510(k) submission. The Senhance robotic-assisted surgery system is designed to improve minimally invasive surgery, namely in laparoscopy operations, through haptic feedback and eye sensing camera control. Get the full story at our sister […]
TransEnterix inks sales agreement to offer $50m in stock
TransEnterix (NYSE:TRXC) said today it inked an at-the-market equity offering sales agreement to sell an aggregate of $50 million in shares of common stock with Stifel, Nicolaus & Co acting as the sales agent. As part of the deal, Stifel will engage in selling shares on the company’s behalf, with Transenterix designating the maximum amount of shares […]
TransEnterix shares rise on Q2 beat
Shares in TransEnterix (NYSE:TRXC) rose today after the robotic surgical device maker met expectations on Wall Street with its 2nd quarter earnings results. The Research Triangle Park, N.C.-based company posted losses of $14.7 million, or 11¢ per share, on sales of $1.6 million for the 3 months ended June 30, seeing losses down 81.9%. Losses per […]
TransEnterix touts 1st micro-laparoscopic robotic surgeries with Senhance
TransEnterix (NYSE:TRXC) today touted that its Senhance Surgical Robot system was used in the 1st 3mm micro laparoscopic robotic surgeries globally. The surgeries were performed at France’s CHU Saint-Ètienne and at Rome’s Policlinico A. Gemelli Foundation, the Research Triangle, N.C.-based company said, by Dr. Celine Chauler, Dr. Salvatore Aletti and Dr. Gabriele Barabino. “Patients are consistently […]